BEDFORD, Mass. (AP) _ Homology Medicines Inc. (FIXX) on Thursday reported a loss of $26.3 million in its second quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 61 cents.
The gene editing company posted revenue of $392,000 in the period.
Homology Medicines shares have fallen 29% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $15.79, a drop of roughly 4% in the last 12 months.